Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors

Journal of Clinical Ultrasound

Volumn 38, Issue 5, 2010, Pages 227-231

  Trojan, Joerg ^a   Hammerstingl, Renate ^a   Engels, Knut ^a   Schneider, Arne R ^b   Zeuzem, Stefan ^a   Dietrich, Christoph F ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

^c CARITAS KRANKENHAUS   (Germany)

Author keywords

Angiosarcoma; Contrast enhanced ultrasound; Hemangioma; Malignant fibrous histiocytoma; Malignant mesenchymal liver tumors

Indexed keywords

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

AGED; ANGIOSARCOMA; ARTICLE; CASE REPORT; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER; LIVER TUMOR; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOSARCOMA; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, DOPPLER;

EID: 77952739915     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20690     Document Type: Article

References (14)

1. Harvey CJ, Blomley MJ, Eckersley RJ, et al. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000;355:807.
2. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 2008;29:28.
3. Dietrich CF, Ignee A, Trojan J, et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004;53:401.
4. Dietrich CF, Schuessler G, Trojan J, et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast enhanced ultrasound. Br J Radiol 2005;78:704.
5. Dietrich CF, Mertens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007;45:1139.
6. Buetow PC, Buck JL, Ros PR, et al. Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiographics 1994;14:153.
7. Kitami M, Yamada T, Sato A, et al. Diffuse hepatic angiosarcoma with a portal venous supply mimicking hemangiomatosis. J Comput Assist Tomogr 2003;27:626.
8. Itai Y, Teraoka T. Angiosarcoma of the liver mimicking cavernous hemangioma on dynamic CT. J Comput Assist Tomogr 1989;13:910.
9. Kim KA, Kim KW, Park SH, et al. Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol 2006;187:W481.
10. Rademaker J, Widjaja A, Galanski M. Hepatic hemangiosarcoma: imaging findings and differential diagnosis. Eur Radiol 2000;10:129.
11. Peterson MS, Baron RL, Rankin SC. Hepatic angiosarcoma: findings on multiphasic contrastenhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol 2000;175:165.
12. Koyama T, Fletcher JG, Johnson CD, et al. Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology 2002;222:667.
13. von Herbay A, Westendorff J, Gregor M. Contrastenhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. J Clin Ultrasound 2010;38:1.
14. Strobel D, Seitz K, Blank W, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 2009;30:376.